Clinafloxacin

Drug Profile

Clinafloxacin

Alternative Names: AM 1091; CI 960; PD 127391

Latest Information Update: 10 Sep 2009

Price : $50

At a glance

  • Originator Pfizer
  • Class Antibacterials; Fluoroquinolones
  • Mechanism of Action DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 09 Mar 2004 A study has been added to the Bacterial Infections therapeutic trials section
  • 15 Feb 2002 A clinical study has been added to the pharmacokinetics section
  • 15 Feb 2002 A study in volunteers has been added to the drug interactions section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top